The value isn't retyping the same structural sections — it's the science, the accuracy, and the review.
A strong, structured draft from your existing data saves time before you write a word.
It's not just more projects — it's better margins on fixed-fee work and fewer review cycles.
Less time on repetitive drafting means more time on the parts that need a human.



> Case, case-control & case series
> Cohort (pro / retrospective)
> Cross-sectional
> Population studies
> Phase I, II, III
> Phase I/II, II/III
> Adaptive, all phases
> FDA & EMA variants
> Phase I
> Phase II
> Phase III — class I
> Phase III — class II & III
> Behavioral
> Bioequivalence
> Therapeutic equivalence
> Bioavailability
> Informed Consent Forms
> Investigator's Brochures
> Manuscripts & publications
> Congress abstracts
> Final study reports
> Drafted from results
> Structured to standard
> Ready for review
ReSkript is powered by AI built for clinical and scientific documentation — not a general chatbot. It was developed by MphaR together with medical writers from pharma, biotech, and CROs, and independent researchers, with decades of experience producing these exact documents. That's why it handles citations, consistency, and compliance the way generic tools don't.
